Purple Biotech (PPBT) Short Interest Ratio & Short Volume → Banking Apocalypse Ahead: Secure Your Savings Today! (From Weiss Ratings) (Ad) Free PPBT Stock Alerts $0.78 -0.01 (-0.84%) (As of 09:37 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Purple Biotech Short Interest DataCurrent Short Interest257,600 sharesPrevious Short Interest297,200 sharesChange Vs. Previous Month-13.32%Dollar Volume Sold Short$128,800.00Short Interest Ratio1.5 Days to CoverLast Record DateMay 15, 2024Outstanding Shares25,240,000 sharesPercentage of Shares Shorted1.02%Today's Trading Volume8,865 sharesAverage Trading Volume139,697 sharesToday's Volume Vs. Average6% Short Selling Purple Biotech ? Sign up to receive the latest short interest report for Purple Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPPBT Short Interest Over TimePPBT Days to Cover Over TimePPBT Percentage of Float Shorted Over Time Ad Porter & CompanyThe Worst is Yet to Come…Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now. Purple Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/2024257,600 shares $128,800.00 -13.3%N/A1.5 $0.50 4/30/2024297,200 shares $153,860.44 +27.3%N/A2 $0.52 4/15/2024233,500 shares $132,324.45 +5.1%N/A2 $0.57 3/31/2024222,200 shares $148,874.00 -0.4%N/A2.3 $0.67 3/15/2024223,000 shares $161,641.55 -24.6%N/A2.2 $0.72 2/29/2024295,900 shares $249,857.96 -6.2%N/A2.9 $0.84 Get the Latest News and Ratings for PPBT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Purple Biotech and its competitors with MarketBeat's FREE daily newsletter. 2/15/2024315,400 shares $239,672.46 -24.6%N/A3.5 $0.76 1/31/2024418,100 shares $275,946.00 -7.7%N/A5.2 $0.66 1/15/2024452,800 shares $312,432.00 -4.7%N/A4.6 $0.69 12/31/2023475,100 shares $370,578.00 -13.5%N/A4.6 $0.78 12/15/2023548,900 shares $521,455.00 +7.8%N/A5.2 $0.95 11/30/2023509,100 shares $529,464.00 -8.6%N/A5.6 $1.04 11/15/2023556,700 shares $578,968.00 -20.5%N/A6.4 $1.04 10/31/2023700,100 shares $945,135.00 -6.5%N/A8.1 $1.35 10/15/2023748,400 shares $950,468.00 +15.9%N/A9.5 $1.27 9/30/2023645,900 shares $768,621.00 -0.1%N/A7.1 $1.19 9/15/2023646,600 shares $724,192.00 -4.7%N/A7.5 $1.12 8/31/2023678,400 shares $820,864.00 -0.5%N/A7.7 $1.21 8/15/2023681,600 shares $763,392.00 -2.5%N/A8 $1.12 7/31/2023698,700 shares $761,583.00 -11.3%N/A8.5 $1.09 7/15/2023787,900 shares $961,238.00 +17.2%N/A11.2 $1.22 6/30/2023672,100 shares $937,579.50 -0.5%N/A11.5 $1.40 6/15/2023675,400 shares $1.08 million -0.3%N/A21.5 $1.60 5/31/2023677,700 shares $1.19 million -0.3%N/A23.6 $1.76 5/15/2023679,900 shares $1.23 million -2.7%N/A22 $1.81 4/30/2023698,800 shares $1.41 million +1.5%N/A19 $2.02 4/15/2023688,600 shares $1.36 million -0.2%N/A16.8 $1.97 3/31/2023690,100 shares $1.24 million -5.7%N/A16.5 $1.79 3/15/2023731,600 shares $1.51 million -0.4%N/A16 $2.07 2/28/2023734,500 shares $1.47 million -3.0%N/A15.7 $2.00 2/15/2023757,400 shares $1.70 million +3.8%N/A16 $2.25 1/31/2023729,800 shares $1.16 million -3.8%N/A16.1 $1.59 1/15/2023758,400 shares $1.21 million -3.9%N/A18.8 $1.59 12/30/2022789,400 shares $1.09 million -5.2%N/A20 $1.38 12/15/2022832,400 shares $1.27 million -3.5%N/A23.6 $1.53 11/30/2022862,200 shares $1.69 million -0.6%N/A21.1 $1.96 11/15/2022867,500 shares $1.87 million -0.5%N/A11 $2.16 10/31/2022871,500 shares $1.86 million -1.0%N/A11.3 $2.13 10/15/2022880,000 shares $1.74 million -0.7%N/A11 $1.98 9/30/2022886,000 shares $1.80 million -4.1%N/A10.7 $2.03This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry 9/15/2022924,100 shares $1.98 million +10.2%N/A10.6 $2.14 8/31/2022838,400 shares $1.97 million -0.6%N/A9.8 $2.35 8/15/2022843,200 shares $2.16 million -3.0%N/A18.6 $2.56 7/31/2022869,600 shares $2.19 million +1.1%N/A16.8 $2.52 7/15/2022859,800 shares $1.96 million -4.3%N/A16.3 $2.28 6/30/2022898,600 shares $2.15 million -3.2%N/A13.4 $2.39 6/15/2022928,400 shares $2.38 million -4.5%N/A12.8 $2.56 5/31/2022971,700 shares $2.80 million -2.8%N/A11.9 $2.88 5/15/20221,000,000 shares $2.92 million -2.0%5.7%11.4 $2.92 4/30/20221,020,000 shares $3.01 million +2.0%5.9%10.7 $2.95 4/15/20221,000,000 shares $3.12 million +2.2%5.7%9.2 $3.12 3/31/2022978,200 shares $3.84 million +5.3%5.6%8.7 $3.93 3/15/2022928,800 shares $2.50 million -4.5%5.3%8.5 $2.69 2/28/2022972,900 shares $2.84 million -2.7%5.6%9.2 $2.92 2/15/20221,000,000 shares $3.06 million +0.9%5.7%9.4 $3.06 1/31/2022991,500 shares $2.54 million -9.0%5.7%9 $2.56 1/15/20221,090,000 shares $4.43 million +0.9%6.3%10 $4.06 12/31/20211,080,000 shares $4.20 million -1.8%6.2%11.1 $3.89 12/15/20211,100,000 shares $4.55 million +5.8%6.3%11.1 $4.14 11/30/20211,040,000 shares $4.13 million +4.0%6.0%9.9 $3.97 11/15/20211,000,000 shares $4.48 million -3.9%5.7%8.4 $4.48 10/29/20211,040,000 shares $4.46 million -4.6%N/A8.2 $4.29 10/15/20211,090,000 shares $4.98 million -3.5%N/A7 $4.57 9/30/20211,130,000 shares $5.18 million -8.1%N/A6.2 $4.58 9/15/20211,230,000 shares $6.14 million -2.4%N/A6.1 $4.99 8/31/20211,260,000 shares $6.25 million +10.5%N/A5.2 $4.96 8/13/20211,140,000 shares $5.38 million -2.6%N/A2.6 $4.72 7/30/20211,170,000 shares $6.46 million +17.4%N/A2.6 $5.52 7/15/2021996,400 shares $4.80 million +2.5%N/A2.3 $4.82 6/30/2021972,400 shares $4.75 million +4.6%N/A2.1 $4.88 6/15/2021929,500 shares $4.86 million +70.7%N/A1.9 $5.23 5/28/2021544,600 shares $2.97 million +54.2%N/A1.2 $5.46 5/14/2021353,200 shares $1.36 million +15.6%N/A1 $3.86 4/30/2021305,500 shares $1.31 million +26.7%N/A0.5 $4.29 4/15/2021241,200 shares $979,272.00 -0.7%N/A0.3 $4.06 3/31/2021243,000 shares $991,440.00 +25.7%N/A0.3 $4.08 3/15/2021193,400 shares $937,990.00 -38.4%N/A0.2 $4.85 2/26/2021314,100 shares $1.52 million -11.1%N/A0.4 $4.85 2/12/2021353,100 shares $2.06 million +90.2%N/A0.4 $5.84 1/29/2021185,700 shares $768,798.00 +82.6%N/A0.3 $4.14 1/15/2021101,700 shares $441,378.00 No ChangeN/A0.2 $4.34 PPBT Short Interest - Frequently Asked Questions What is Purple Biotech's current short interest? Short interest is the volume of Purple Biotech shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 257,600 shares of PPBT short. Learn More on Purple Biotech's current short interest. What is a good short interest ratio for Purple Biotech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PPBT shares currently have a short interest ratio of 2.0. Learn More on Purple Biotech's short interest ratio. Is Purple Biotech's short interest increasing or decreasing? Purple Biotech saw a decline in short interest in May. As of May 15th, there was short interest totaling 257,600 shares, a decline of 13.3% from the previous total of 297,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Purple Biotech's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Purple Biotech: Kiora Pharmaceuticals, Inc. (0.28%), MIRA Pharmaceuticals, Inc. (0.15%), Flora Growth Corp. (2.82%), Vincerx Pharma, Inc. (1.92%), Pieris Pharmaceuticals, Inc. (2.03%), Edesa Biotech, Inc. (0.47%), RedHill Biopharma Ltd. (2.05%), FSD Pharma Inc. (0.93%), Oragenics, Inc. (2.07%), Imunon, Inc. (3.80%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Purple Biotech stock? Short selling PPBT is an investing strategy that aims to generate trading profit from Purple Biotech as its price is falling. PPBT shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Purple Biotech? A short squeeze for Purple Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PPBT, which in turn drives the price of the stock up even further. How often is Purple Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PPBT, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Anixa Biosciences Short Interest Data Cue Biopharma Short Interest Data Spero Therapeutics Short Interest Data Hookipa Pharma Short Interest Data Genelux Short Interest Data Aclaris Therapeutics Short Interest Data Annovis Bio Short Interest Data vTv Therapeutics Short Interest Data Aileron Therapeutics Short Interest Data Journey Medical Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PPBT) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWrite this ticker symbol down…StocksToTradeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap Profits4 Cryptos BETTER than BitcoinTrue Market InsidersBill Clinton Backing Biden Replacement???The Freeport SocietyYou won't believe what Citigroup just did to it's depositorsAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Purple Biotech Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.